Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 2
2006 1
2007 1
2008 4
2009 4
2010 1
2011 3
2012 3
2013 3
2014 3
2015 1
2016 1
2017 1
2018 5
2019 2
2020 2
2021 5
2022 4
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.
Dogan I, Aydin E, Khanmammadov N, Paksoy N, Ferhatoğlu F, Ak N, Emiroglu S, Ibis K, Onder S, Tukenmez M, Cabioglu N, Kucucuk S, Muslumanoğlu M, Ozmen V, Saip P, Igci A, Aydiner A. Dogan I, et al. Among authors: igci a. J Cancer Res Clin Oncol. 2023 Nov;149(16):14833-14841. doi: 10.1007/s00432-023-05276-y. Epub 2023 Aug 18. J Cancer Res Clin Oncol. 2023. PMID: 37594533
Evaluation of Benign Breast Diseases With or Without Atypical Epithelial Hyperplasia Accompanying Radial Scars.
Turkyilmaz Z, Sarisik E, Ozkurt E, Tukenmez M, Emiroglu S, Emiroglu B, Onder S, Yilmaz R, Muslumanoglu M, Igci A, Ozmen V, Cabioglu N. Turkyilmaz Z, et al. Among authors: igci a. Eur J Breast Health. 2023 Apr 1;19(2):166-171. doi: 10.4274/ejbh.galenos.2023.2022-10-4. eCollection 2023 Apr. Eur J Breast Health. 2023. PMID: 37025577 Free PMC article.
Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.
Oner G, Önder S, Karatay H, Ak N, Tükenmez M, Müslümanoğlu M, İğci A, Dincçağ A, Özmen V, Aydiner A, Yavuz E, Cabioğlu N. Oner G, et al. Among authors: igci a. World J Surg Oncol. 2023 Feb 21;21(1):54. doi: 10.1186/s12957-023-02931-z. World J Surg Oncol. 2023. PMID: 36810121 Free PMC article. No abstract available.
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes.
Özkurt E, Emiroğlu S, Cabioğlu N, Karanlık H, Önder S, Tükenmez M, İğci A, Özmen V, Müslümanoğlu M. Özkurt E, et al. Among authors: igci a. Breast Care (Basel). 2022 Dec;17(6):554-560. doi: 10.1159/000525324. Epub 2022 Jun 2. Breast Care (Basel). 2022. PMID: 36590148 Free PMC article.
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Mollavelioglu B, Cetin Aktas E, Cabioglu N, Abbasov A, Onder S, Emiroglu S, Tükenmez M, Muslumanoglu M, Igci A, Deniz G, Ozmen V. Mollavelioglu B, et al. Among authors: igci a. World J Surg Oncol. 2022 Oct 21;20(1):349. doi: 10.1186/s12957-022-02810-z. World J Surg Oncol. 2022. PMID: 36271406 Free PMC article.
51 results